Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 141123
                    [Title] => No proof of increase heart-related problems associated with rofecoxib- Circulation report shows
                    [Summary] => An extensive report and analysis which was published recently in the on-line edition of "Circulation," one of the leading and respected journals, showed that  there was no significant evidence to prove that the arthritic drug rofecoxib increases the incidence of cardiovascular problems when compared to a placebo (sugar pill) and to traditional non-naproxen non-steroidal anti-inflammatory drugs (NSAIDs).



                    [DatePublished] => 2001-11-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

ANTIPLATELET TRIALIST

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 141123
                    [Title] => No proof of increase heart-related problems associated with rofecoxib- Circulation report shows
                    [Summary] => An extensive report and analysis which was published recently in the on-line edition of "Circulation," one of the leading and respected journals, showed that  there was no significant evidence to prove that the arthritic drug rofecoxib increases the incidence of cardiovascular problems when compared to a placebo (sugar pill) and to traditional non-naproxen non-steroidal anti-inflammatory drugs (NSAIDs).



                    [DatePublished] => 2001-11-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

No proof of increase heart-related problems associated with rofecoxib- Circulation report shows

November 23, 2001 - 12:00am

An extensive report and analysis which was published recently in the on-line edition of "Circulation," one of the leading and respected journals, showed that there was no significant evidence to prove...

Health And Family